Healthcare provider profile · identity verified

Jill M Rogers, MD

Family Practice · INDIANAPOLIS, IN · NPI 1235308149

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	326	97
Atorvastatin Calcium	Atorvastatin Calcium	315	84
Simvastatin	Simvastatin	264	69
Lisinopril	Lisinopril	203	59
Hydrochlorothiazide	Hydrochlorothiazide	199	59
Levothyroxine Sodium	Levothyroxine Sodium	179	52
Losartan Potassium	Losartan Potassium	158	44
Albuterol Sulfate Hfa	Albuterol Sulfate	129	39
Omeprazole	Omeprazole	129	34
Sertraline Hcl	Sertraline Hcl	119	30
Metoprolol Succinate	Metoprolol Succinate	118	34
Metformin Hcl	Metformin Hcl	111	32
Rosuvastatin Calcium	Rosuvastatin Calcium	91	32
Pantoprazole Sodium	Pantoprazole Sodium	88	24
Metformin Hcl Er	Metformin Hcl	78	26
Gabapentin	Gabapentin	77	24
Trazodone Hcl	Trazodone Hcl	73	18
Meloxicam	Meloxicam	67	15
Ozempic	Semaglutide	61	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	15
Alendronate Sodium	Alendronate Sodium	52	17
Potassium Chloride	Potassium Chloride	51	15
Fluoxetine Hcl	Fluoxetine Hcl	44	12
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	20
Glipizide Er	Glipizide	43	11
Metoprolol Tartrate	Metoprolol Tartrate	43	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	12
Bupropion Xl	Bupropion Hcl	41	13
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Tamsulosin Hcl	Tamsulosin Hcl	41	14
Duloxetine Hcl	Duloxetine Hcl	39	12
Montelukast Sodium	Montelukast Sodium	37	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Furosemide	Furosemide	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	12
Allopurinol	Allopurinol	33	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Carvedilol	Carvedilol	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Eliquis	Apixaban	25	suppressed
Jardiance	Empagliflozin	24	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	22	22
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	21
Trulicity	Dulaglutide	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Valsartan	Valsartan	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Famotidine	Famotidine	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Baclofen	Baclofen	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Torsemide	Torsemide	16	suppressed
Linzess	Linaclotide	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Prednisone	Prednisone	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error